Can a simple test predict who will beat skin cancer with immunotherapy?
NCT ID NCT06536257
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 2 times
Summary
This study is testing a new predictive model that analyzes tumor samples to forecast whether a patient with melanoma or other skin cancers will respond to immunotherapy. Researchers will compare the model's predictions with actual patient outcomes over six months. The goal is to see if this tool can help doctors personalize treatment decisions, potentially sparing non-responders from unnecessary side effects. The study plans to enroll 1,000 participants.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help doctors choose the right immunotherapy for each patient, avoiding ineffective treatments and their side effects.
What could go wrong
This is an observational study, not a treatment trial. The model may not be accurate enough to change practice, and results may not apply to all skin cancer types.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chris O'Brien Lifehouse
RECRUITINGSydney, New South Wales, 2050, Australia
Contact
Contact Email: •••••@•••••
-
Melanoma Institute Australia
RECRUITINGSydney, New South Wales, 2065, Australia
Contact
Contact
Contact Email: •••••@•••••
Contact
Contact
Contact
Contact
-
Westmead Hospital
RECRUITINGSydney, New South Wales, 2145, Australia
Contact Email: •••••@•••••